(Q34266395)

1 August 2017

1 reference

title

The OGTT as test for beta cell function? (English)

1 reference

1 August 2017

3

Häring H

1 reference

1 August 2017

1

Stumvoll M

1 reference

1 August 2017

2

Fritsche A

1 reference

1 August 2017

publication date

1 May 2001

1 reference

European Journal of Clinical Investigation

1 August 2017

published in

1 reference

1 August 2017

volume

31

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

380-381

1 reference

The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Decreased Insulin Secretion and Increased Insulin Resistance Are Independently Related to the 7-Year Risk of NIDDM in Mexican-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

Genomewide search for type 2 diabetes susceptibility genes in four American populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00828.X

10.1046/J.1365-2362.2001.00828.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference